Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Obstetrics & Gynecology 1996;87:506-510
© 1996 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hyett, J.
Right arrow Articles by Nicolaides, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hyett, J.
Right arrow Articles by Nicolaides, K.

Articles

Cardiac gene expression of atrial natriuretic peptide and brain natriuretic peptide in trisomic fetuses

JA Hyett, ML Brizot, CS Von Kaisenberg, AT McKie, F Farzaneh, and KH Nicolaides

OBJECTIVE: To investigate whether the increased nuchal translucency of trisomic fetuses is the consequence of heart failure by examining cardiac expression of atrial natriuretic peptide and brain natriuretic peptide genes. METHODS: Cardiac atrial natriuretic peptide and brain natriuretic peptide messenger RNA (mRNA) levels were measured in fetal hearts from 15 pregnancies affected by trisomy 21 or 18 at 12-16 weeks' gestation and from 30 normal controls at 10-20 weeks. RESULTS: In normal fetuses, mRNA levels of atrial natriuretic peptide decreased, but levels of brain natriuretic peptide did not change significantly with gestation. In trisomic fetuses, mRNA levels of both atrial natriuretic peptide and brain natriuretic peptide were significantly higher than in gestational age-matched normal controls. CONCLUSION: These data demonstrate that atrial natriuretic peptide and brain natriuretic peptide genes are transcribed prenatally, and the findings in trisomic fetuses suggest that the increased translucency of trisomic fetuses may be the consequence of heart failure.


This article has been cited by other articles:


Home page
 Hum ReprodHome page
C.S. von Kaisenberg, F. Prols, K.H. Nicolaides, N. Maass, I. Meinhold-Heerlein, and B. Brand-Saberi
Glycosaminoglycans and proteoglycans in the skin of aneuploid fetuses with increased nuchal translucency
Hum. Reprod., December 1, 2003; 18(12): 2544 - 2561.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
R. Maymon, E. Jauniaux, O. Cohen, E. Dreazen, Z. Weinraub, and A. Herman
Pregnancy outcome and infant follow-up of fetuses with abnormally increased first trimester nuchal translucency
Hum. Reprod., September 1, 2000; 15(9): 2023 - 2027.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
S. Bohlandt, C.S. von Kaisenberg, K. Wewetzer, B. Christ, K.H. Nicolaides, and B. Brand-Saberi
Hyaluronan in the nuchal skin of chromosomally abnormal fetuses
Hum. Reprod., May 1, 2000; 15(5): 1155 - 1158.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
R. Maymon, A. Herman, E. Dreazen, Y. Tovbin, I. Bukovsky, and Z. Weinraub
Case Report: Can nuchal cord cause transient increased nuchal translucency thickness?
Hum. Reprod., February 1, 1999; 14(2): 556 - 559.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American College of Obstetricians and Gynecologists.